Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 218Rectal Neoplasms 107Colonic Neoplasms 91Pancreatic Neoplasms 88Stomach Neoplasms 75Neoplasm Metastasis 61Esophageal Neoplasms 40Carcinoma, Hepatocellular 31Lymphoma 24Adenocarcinoma Of Esophagus 24Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Adenocarcinoma 19Leukemia 17Cholangiocarcinoma 15Biliary Tract Neoplasms 15Burkitt Lymphoma 14Gastrointestinal Neoplasms 12Lymphoma, Non-Hodgkin 11Osteosarcoma 9Liver Neoplasms 9Gallbladder Neoplasms 9Esophageal Squamous Cell Carcinoma 9Peritoneal Neoplasms 8Leukemia, Myeloid, Acute 8Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 7Bile Duct Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 6Multiple Myeloma 6

Interventions

folfirinox 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Pancreaticoduodenectomy 1Magnetic Resonance Spectroscopy 1Leucovorin 1Laparoscopy 1Gemcitabine 1Fluorouracil 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Pancreatic Adenocarcinoma × Leucovorin × Clear all
NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Oslo University Hospital

Active not recruiting
251 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡